Axogen, Inc. is 1.7x more valuable than BIOLIFE SOLUTIONS INC by market capitalization ($2.20 B vs $1.30 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AXGN | BLFS |
|---|---|---|
| Market cap | $2.20 B | $1.30 B |
| US-listed rank | #2035 | #2436 |
| Revenue (latest FY) | $225.21M | $96.21M |
| Net income (latest FY) | -$15.70M | -$4.59M |
| Net margin | -7.0% | -4.8% |
| SEC filings | 1,334 | 1,679 |
Axogen, Inc. is 1.7x more valuable than BIOLIFE SOLUTIONS INC by market capitalization ($2.20 B vs $1.30 B).
In their latest fiscal years, Axogen, Inc. reported $225.21M in revenue while BIOLIFE SOLUTIONS INC reported $96.21M.
Full pages: Axogen, Inc. and BIOLIFE SOLUTIONS INC, or browse the full rankings.